Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pivotal, International, Randomised, Double-blind, Efficacy and Safety Trial of Sodium Valproate, in Paediatric and Adult Patients With Wolfram Syndrome

NCT03717909 is registered in ClinicalTrials.gov with University of Birmingham as lead sponsor.

NCT NCT03717909
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03717909 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pivotal, International, Randomised, Double-blind, Efficacy and Safety Trial of Sodium Valproate, in Paediatric and Adult Patients With Wolfram Syndrome
Lead sponsor
University of Birmingham
Phase
Phase 2
Overall status
Completed
Start date
December 28, 2018
Completion date
November 15, 2024
Enrollment
63 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

wolfram syndrome